| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
On November 12, 2025, SCHMID Group N.V. ("SCHMID" or the "Company") received a staff determination letter (the "Determination Letter") from the staff of the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq"). The Determination Letter notified that, based upon the Company's non-compliance with the filing requirement set forth in Nasdaq Listing Rule 5250(c)(1) as of November 12, 2025, the staff had determined to delist the Company's ordinary shares and warrants from Nasdaq unless the Company timely appeals the staff's determination before the Nasdaq Hearings Panel (the "Panel").
The Company intends to timely appeal the determination by Nasdaq pursuant to the procedures set forth in the Nasdaq Listing Rules. The Listing Rules also provide that a request for a hearing will stay the suspension of the listing of Company's ordinary shares and warrants for a period of 15 days from the date of the request. Further, the Listing Rules provide that, in its hearing request, the Company may request that the stay remain in effect through the hearing and the expiration of any additional extension period granted by the Panel following the hearing. Accordingly, the Company intends to make such an extended stay request. If granted, the Company's ordinary shares and warrants will continue to be listed and trade on The Nasdaq Capital Market under the symbol "SHMD," respectively, for the stay period granted by the Panel.
The Company is diligently working to complete and file the Annual Report on Form 20-F for the year ended December 31, 2024 (the "2024 Annual Report"), with the Securities and Exchange Commission (the "SEC") as soon as practicable. There can be no assurance, however, that the Company's requests for a further stay of any suspension action by Nasdaq and the continued listing of its ordinary shares and warrants will be granted by the Panel, or that the Company will be able to evidence compliance with all applicable requirements for continued listing on The Nasdaq Capital Market should the Panel grant the Company an extension to do so.
The receipt of the Determination Letter does not affect the Company's business, operations or reporting requirements with the Securities and Exchange Commission.
Posted In: SHMD
